Synthesis and In Vitro Evaluation of Novel Liver X Receptor Agonists Based on Naphthoquinone Derivatives

Overview

Journal Molecules

Publisher MDPI

Specialty Biology

Date 2019 Nov 30

PMID 31779181

Citations 4

Authors

Tatsuma Nishioka

Kaori Endo-Umeda

Yuki Ito

Akane Shimoda

Atsuko Takeuchi

Chisato Tode

Yoshihisa Hirota

Naomi Osakabe

Makoto Makishima

Yoshitomo Suhara

Affiliations

Soon will be listed here.

Abstract

We aimed to synthesize novel liver X receptor (LXR) agonists with potent agonist activity and subtype selectivity. Our synthetic scheme started with naphthoquinone derivatives, such as menadione and 2,3-dichloro-1,4-naphthoquinone. We introduced different substituents into the naphthoquinone structures, including aniline, piperidine, pyrrolidine, and morpholine, in one or two steps, and thus, we produced 14 target compounds. All 14 synthetic ligands were tested to determine whether they mediated LXR-mediated transcriptional activity. We investigated the transcriptional activity of each compound with two types of receptors, LXRα and LXRβ. Among all 14 compounds, two showed weak LXRβ-agonist activity, and two others exhibited potent LXRα-agonist activity. We also performed docking studies to obtain a better understanding of the modes of compound binding to LXR at the atomic level. In conclusion, we successfully synthesized naphthoquinone derivatives that act as LXRα/β agonists and selective LXRα agonists.

Citing Articles

Microwave-Promoted Total Synthesis of Puniceloid D for Modulating the Liver X Receptor.

Jung Y, Hosseininasab N, Park J, Hyun S, Jung J, Kwak J Molecules. 2024; 29(2).

PMID: 38257329 PMC: 10821398. DOI: 10.3390/molecules29020416.

Exploring Novel Vitamin K Derivatives with Anti-SARS-CoV-2 Activity.

Homma T, Okamoto M, Koharazawa R, Hayakawa M, Fushimi T, Tode C ACS Omega. 2023; 8(45):42248-42263.

PMID: 38024673 PMC: 10652723. DOI: 10.1021/acsomega.3c04175.

Exploring the Antimicrobial and Antitumoral Activities of Naphthoquinone-Grafted Chitosans.

Petzold Pauli F, Freitas C, Pereira P, Magalhaes A, de Carvalho da Silva F, Paschoalin V Polymers (Basel). 2023; 15(6).

PMID: 36987212 PMC: 10053705. DOI: 10.3390/polym15061430.

Interaction of Odoroside A, A Known Natural Cardiac Glycoside, with Na/K-ATPase.

Takada Y, Kaneko K, Kawakami Y J Membr Biol. 2023; 256(3):229-241.

PMID: 36840763 DOI: 10.1007/s00232-023-00281-1.

References

Song C, Hiipakka R, Liao S . Selective activation of liver X receptor alpha by 6alpha-hydroxy bile acids and analogs. Steroids. 2000; 65(8):423-7. DOI: 10.1016/s0039-128x(00)00127-6. View

Tandon V, Maurya H, Verma M, Kumar R, Shukla P . 'On water' assisted synthesis and biological evaluation of nitrogen and sulfur containing hetero-1,4-naphthoquinones as potent antifungal and antibacterial agents. Eur J Med Chem. 2010; 45(6):2418-26. DOI: 10.1016/j.ejmech.2010.02.023. View

Kennedy M, Venkateswaran A, Tarr P, Xenarios I, Kudoh J, Shimizu N . Characterization of the human ABCG1 gene: liver X receptor activates an internal promoter that produces a novel transcript encoding an alternative form of the protein. J Biol Chem. 2001; 276(42):39438-47. DOI: 10.1074/jbc.M105863200. View

Kongkathip B, Akkarasamiyo S, Hasitapan K, Sittikul P, Boonyalai N, Kongkathip N . Synthesis of novel naphthoquinone aliphatic amides and esters and their anticancer evaluation. Eur J Med Chem. 2013; 60:271-84. DOI: 10.1016/j.ejmech.2012.12.006. View

Zhang W, Liu M, Yang L, Huang F, Lan Y, Li H . P-glycoprotein Inhibitor Tariquidar Potentiates Efficacy of Astragaloside IV in Experimental Autoimmune Encephalomyelitis Mice. Molecules. 2019; 24(3). PMC: 6384695. DOI: 10.3390/molecules24030561. View

Venkateswaran A, Laffitte B, Joseph S, Mak P, Wilpitz D, Edwards P . Control of cellular cholesterol efflux by the nuclear oxysterol receptor LXR alpha. Proc Natl Acad Sci U S A. 2000; 97(22):12097-102. PMC: 17300. DOI: 10.1073/pnas.200367697. View

Kick E, Busch B, Martin R, Stevens W, Bollu V, Xie Y . Discovery of Highly Potent Liver X Receptor β Agonists. ACS Med Chem Lett. 2016; 7(12):1207-1212. PMC: 5150697. DOI: 10.1021/acsmedchemlett.6b00234. View

Honzumi S, Shima A, Hiroshima A, Koieyama T, Ubukata N, Terasaka N . LXRalpha regulates human CETP expression in vitro and in transgenic mice. Atherosclerosis. 2010; 212(1):139-45. DOI: 10.1016/j.atherosclerosis.2010.04.025. View

Nomura S, Endo-Umeda K, Makishima M, Hashimoto Y, Ishikawa M . Development of Tetrachlorophthalimides as Liver X Receptor β (LXRβ)-Selective Agonists. ChemMedChem. 2016; 11(20):2347-2360. DOI: 10.1002/cmdc.201600305. View

10.

Cramer P, Cirrito J, Wesson D, Lee C, Karlo J, Zinn A . ApoE-directed therapeutics rapidly clear β-amyloid and reverse deficits in AD mouse models. Science. 2012; 335(6075):1503-6. PMC: 3651582. DOI: 10.1126/science.1217697. View

11.

Svensson S, Ostberg T, Jacobsson M, Norstrom C, Stefansson K, Hallen D . Crystal structure of the heterodimeric complex of LXRalpha and RXRbeta ligand-binding domains in a fully agonistic conformation. EMBO J. 2003; 22(18):4625-33. PMC: 212723. DOI: 10.1093/emboj/cdg456. View

12.

Benites J, Valderrama J, Bettega K, Pedrosa R, Buc Calderon P, Verrax J . Biological evaluation of donor-acceptor aminonaphthoquinones as antitumor agents. Eur J Med Chem. 2010; 45(12):6052-7. DOI: 10.1016/j.ejmech.2010.10.006. View

13.

Swahn B, Macsari I, Viklund J, Ohberg L, Sjodin J, Neelissen J . Liver X receptor agonists with selectivity for LXRbeta; N-aryl-3,3,3-trifluoro-2-hydroxy-2-methylpropionamides. Bioorg Med Chem Lett. 2009; 19(7):2009-12. DOI: 10.1016/j.bmcl.2009.02.039. View

14.

Namjoshi D, Martin G, Donkin J, Wilkinson A, Stukas S, Fan J . The liver X receptor agonist GW3965 improves recovery from mild repetitive traumatic brain injury in mice partly through apolipoprotein E. PLoS One. 2013; 8(1):e53529. PMC: 3547922. DOI: 10.1371/journal.pone.0053529. View

15.

Corbeil C, Williams C, Labute P . Variability in docking success rates due to dataset preparation. J Comput Aided Mol Des. 2012; 26(6):775-86. PMC: 3397132. DOI: 10.1007/s10822-012-9570-1. View

16.

Stachel S, Zerbinatti C, Rudd M, Cosden M, Suon S, Nanda K . Identification and in Vivo Evaluation of Liver X Receptor β-Selective Agonists for the Potential Treatment of Alzheimer's Disease. J Med Chem. 2016; 59(7):3489-98. DOI: 10.1021/acs.jmedchem.6b00176. View

17.

Schultz J, Tu H, Luk A, REPA J, Medina J, Li L . Role of LXRs in control of lipogenesis. Genes Dev. 2000; 14(22):2831-8. PMC: 317060. DOI: 10.1101/gad.850400. View